Blasco E, Gutiérrez-Hoyos A, Garrido C, Arozena F
Servicios de Anatomía Patológica y Urología, Hospital Nuestra Señora de Aranzazu, San Sebastián, España.
Arch Esp Urol. 1991 Jan-Feb;44(1):47-52.
Due to the diversity of the biologic behaviour of the low-grade and low-stage superficial bladder carcinomas, particularly those that present a high recurrence rate, most of the research has been oriented towards finding prognostic markers of recurrence and future invasion of the tumor. Among these markers there are two that have demonstrated their usefulness: the study of the contents of the cellular DNA by flow cytometry and the study of blood group antigens. The latter are carbohydrate structures that form a complex, genetically-regulated signal code which intervenes in the cellular growth and maturation processes. Recently published works describing genetic alterations in transitional bladder carcinomas, oncogenic mutations, loss of the 9q chromosome that regulates the formation of A and B antigens, support the hypothesis that in neoplastic transformation processes, genetic alterations cause enzymatic deficiencies and disorders, and these produce several antigenic changes of the cellular membrane and thus interfere in the biologic behaviour of the malignant cell.
由于低级别、低分期浅表性膀胱癌生物学行为的多样性,尤其是那些具有高复发率的膀胱癌,大多数研究都致力于寻找肿瘤复发和未来侵袭的预后标志物。在这些标志物中,有两种已证明其有用性:通过流式细胞术研究细胞DNA含量以及研究血型抗原。后者是碳水化合物结构,形成一种复杂的、受基因调控的信号密码,参与细胞生长和成熟过程。最近发表的描述移行性膀胱癌基因改变、致癌突变、调节A和B抗原形成的9号染色体缺失的研究成果,支持了这样一种假说,即在肿瘤转化过程中,基因改变会导致酶缺陷和紊乱,进而产生细胞膜的多种抗原变化,从而干扰恶性细胞的生物学行为。